The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

被引：0
|
作者：
Ahmed Yahia Elmowafy
Mohamed Hamed Abbas
Ahmed Abdelfattah Denewar
Mohamed Elsayed Mashaly
Gamal Shiha
Salwa Mahmoud El Wasif
Lionel Rostaing
Mohamed Adel Bakr
机构：
[1] Mansoura University,Urology and Nephrology Center
[2] Egyptian Liver Research Institute and Hospital,Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation Rénale
[3] Université Grenoble Alpes,undefined
[4] CHU Grenoble-Alpes,undefined
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; HCV infection; Sofosbuvir; Daclatasvir; Anemia; Kidney transplantation; Hemodialysis; DAA therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 761
页数：12
相关论文
共 50 条
  • [41] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [42] Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection
    Thibault, Vincent
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03): : 145 - 147
  • [43] Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
    Alswat, Khalid
    Al-Sohaibani, Fahad
    Khathlan, Abdullah
    Bashmail, Ahmad
    Alanazi, Mohammed
    Kurdi, Amr
    Almakadma, Abdul Hakim
    Al-Hamoudi, Waleed
    ANNALS OF SAUDI MEDICINE, 2022, 42 (02) : 89 - 95
  • [44] SHORT-DURATION OF DIRECT-ACTING ANTIVIRALS IN CANCER PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Yibirin, Marcel
    Yepez-Guevara, Eduardo
    Granwehr, Bruno
    Pundhir, Pooja
    Torres, Harrys A.
    HEPATOLOGY, 2020, 72 : 573A - 574A
  • [45] Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
    Dogrugorun, Ayla
    Kartal, Elif Doyuk
    Alpat, Saygin Nayman
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (03): : 95 - 100
  • [46] Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study
    Villani, R.
    Donatiello, I.
    Barone, F.
    Cavallone, F.
    Fioravanti, G.
    Di Cosimo, F.
    Bellanti, F.
    Sollitto, F.
    Vendemiale, G.
    Serviddio, G.
    JOURNAL OF GERONTOLOGY AND GERIATRICS, 2018, 66 (02): : 46 - 55
  • [47] High efficacy and safety of direct-acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam
    Vo, Thong Duy
    Bui, Van Thi Thu
    Lam, Huong Tu
    Bui, Quynh Thi Huong
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (05):
  • [48] Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
    Mohamed Gamal Ibrahim
    Ahmed Abdelrahman Sharafeldin
    Nevine Ibrahim Mousa
    Tarek Khairy Mousa
    Ahmed Mohamed El Missiri
    The Egyptian Heart Journal, 72
  • [49] Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
    Ibrahim, Mohamed Gamal
    Sharafeldin, Ahmed Abdelrahman
    Mousa, Nevine Ibrahim
    Mousa, Tarek Khairy
    El Missiri, Ahmed Mohamed
    EGYPTIAN HEART JOURNAL, 2020, 72 (01):
  • [50] Reduction of liver stiffness by direct-acting antivirals for chronic hepatitis C
    Kawabe, Naoto
    Kan, Toshiki
    Takamura, Tomoki
    Nomura, Sayuri
    Hashimoto, Senju
    Murao, Michihito
    Nakano, Takuji
    Nakaoka, Kazunori
    Ohki, Masashi
    Yuka, Ochi
    Kurashita, Takamitsu
    Fukui, Aiko
    Nishikawa, Toru
    Osakabe, Keisuke
    Ichino, Naohiro
    Yoshioka, Kentaro
    HEPATOLOGY, 2016, 64 : 462A - 462A
12345